Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 study of bevacizumab (Avastin) plus crossover fluoropyrimidine-based chemotherapy in metastatic colorectal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-07-30